Network identification

PURI

https://redirect.ema.europa.eu/resource/37277

Network ID

37277

Network name and Acronym

Vaccine monitoring Collaboration for Europe (VAC4EU)

Network countries

Belgium
Denmark
Finland
France
Germany
Italy
Netherlands
Norway
Spain
United Kingdom

Network website

ENCePP partner

Yes
Network description
VAC4EU is a multi-stakeholder non-for profit international association with a study network to run post-licensure vaccine studies and an open community for scientific debate in Europe. VAC4EU (Vaccine monitoring Collaboration for Europe) is the sustainability solution of the IMI funded ADVANCE project which ended March 2019.
Network details
Network primary therapeutic area:
Infectious diseases
Network funding:
Pharmaceutical company and other private sector 
Non-for-profit organisation (e.g. charity)
EU institutional research programme
Other

Contact

Institutions that are part of this network

Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGY
Drug Safety Research Unit (DSRU)
Porto Pharmacovigilance Centre, Faculty of Medicine, University of Porto (UFPorto)
RTI Health Solutions (RTI-HS)
Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAPJGol
Julius Clinical Research
Bordeaux PharmacoEpi, University of Bordeaux

Studies conducted by the network

A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources (COVID-19)
ACCESS template protocol for safety of COVID-19 vaccines
ACCESS template protocols for effectiveness of COVID-19 vaccines (ACCESS-effectiveness)
An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using European Healthcare Data through VAC4EU (COVID-19)
Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination (ECVM)
Coverage of COVID-19 vaccines in electronic healthcare databases: a protocol template from the ACCESS project
Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen (Covid Vaccines Effectiveness (CoVE))
Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries (COVID-19)
Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Post-Authorisation Active Surveillance Study of Myocarditis and Pericarditis Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Post-Authorisation Safety Study of Comirnaty Original/Omicron BA.1 and Comirnaty Original/Omicron BA.4-5 in Europe
Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe (COVID-19)
Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources (CVM Covid19-Vaccine-Monitor-EHR)
SAFETY-VAC: Background incidence estimation of flares of pre-existing chronic diseases using pan-European electronic healthcare data sources. (SAFETY VAC)
SAFETY-VAC: Network of Data Sources for Vaccine Safety Evaluation
VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe
VAC4EU Postauthorisation Safety Study of BIMERVAX® Vaccine in Europe